Literature DB >> 23210753

Management of ungual warts.

Jordana Herschthal1, Michael P McLeod, Martin Zaiac.   

Abstract

Warts are the most common nail tumor generally caused by human papilloma virus (HPV) 1, 2, 4, 27, and 57. HPV 16 and 18 are associated with malignant transformation to squamous cell carcinoma, while HPV 2 and 7 are associated with "butcher's warts." Current treatments range from topical and intralesional therapies to systemic agents and surgical procedures. Despite the numerous available possibilities for treatment, intralesional bleomycin appears to be the most effective treatment for periungual warts.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23210753     DOI: 10.1111/j.1529-8019.2012.01509.x

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  6 in total

Review 1.  Human Papillomavirus Laboratory Testing: the Changing Paradigm.

Authors:  Eileen M Burd
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

2.  Multipuncture technique with ingenol mebutate in the treatment of a periungual wart.

Authors:  Gerson Dellatorre; Anarosa Barbosa Sprenger
Journal:  An Bras Dermatol       Date:  2018 Sep-Oct       Impact factor: 1.896

Review 3.  Consideration of underlying immunodeficiency in refractory or recalcitrant warts: A review of the literature.

Authors:  J Zampella; B Cohen
Journal:  Skin Health Dis       Date:  2022-02-09

4.  Efficacy and Safety of Intralesional Bleomycin in the Management of Ungual Warts.

Authors:  Archana Singal; Chander Grover
Journal:  Skin Appendage Disord       Date:  2020-10-14

5.  Finger-shaped Red Light Emitting Diode to Ascertain the Depth of Periungual Wart.

Authors:  Balakrishnan Nirmal
Journal:  J Cutan Aesthet Surg       Date:  2016 Jul-Sep

Review 6.  Current trends in needle-free jet injection: an update.

Authors:  Daniel Barolet; Antranik Benohanian
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-05-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.